Y H Luo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Y H Luo

Showing results (51-60 of 52) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 52 results.

Physical Review Letters|December 3, 2016

Experimental Ten-Photon EntanglementXi-Lin Wang, Luo-Kan Chen, W Li, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025

Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH studyF de Marinis, T M Kim, L Bonanno, et al.

Pageof 6

Search research articles

Showing results (51-60 of 52) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 52 results.

Physical Review Letters|December 3, 2016

Experimental Ten-Photon EntanglementXi-Lin Wang, Luo-Kan Chen, W Li, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2025

Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH studyF de Marinis, T M Kim, L Bonanno, et al.

Pageof 6